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We studied the persistence of porcine reproductive and respiratory syndrome virus (PRRSV) in individual
experimentally infected pigs, during a period of up to 150 days postinfection (dpi). The results of this study
suggest that the persistence of PRRSV involves continuous viral replication but that it is not a true steady-state
persistent infection. The virus eventually clears the body and seems to do it in most of the animals by 150 dpi
or shortly thereafter. High genetic stability was seen for several regions of the persistent PRRSV’s genome,
although some consistent mutations in the genes of envelope glycoproteins and M protein were also observed.
Previous reports indicate that porcine reproductive and re-
spiratory syndrome virus (PRRSV) can persist in pigs for long
periods of time after initial infection and that persistently in-
fected animals can shed infectious virus (4, 5, 17, 19). The
mechanisms by which or the condition in which PRRSV per-
sists in the animal host is not known. Few studies of the oc-
currence of in vivo persistence of PRRSV have been reported
(4, 14). Likewise, the genetic stability of PRRSV during per-
sistence is unknown. The genetic stability of ORF7 (the gene
coding for the PRRSV nucleocapsid) has been studied during
serial in vivo passages (10). Likewise, a segment of 537 nucle-
otides comprising the carboxyl-terminal end of ORF4 and the
amino-terminal end of ORF5 has been studied in individual
persistently infected animals (14). While the ORF7 sequence
was reported to be highly stable during persistence in a group
of animals (9, 10), the ectodomain of ORF5 has shown muta-
tions that were suggested to be associated with persistence in
individual hosts (14).
We experimentally infected pigs with the pathogenic PRRSV
isolate 16244B (2) to study the extent of PRRSV gene expres-
sion during persistence in the natural host. We also deter-
mined the genetic stability of the persistent isolates (those
recovered sequentially from an individual animal) by analyzing
some selected areas of the genome. The genomic areas studied
included those probably important for polymerase recognition,
replication initiation, and subgenomic RNA synthesis; the cod-
ing sequence for the structural and NSP1a proteins; and the 59
and 39 noncoding regions (NCRs).
Ten pigs (1 to 2 months old) from an unvaccinated PRRSV-
free herd were inoculated intranasally with 106.0 50% cell
culture infectious doses of PRRSV strain 16244B per ml,
delivered in volumes of 0.5 ml/nostril. Three uninfected pigs,
matching the infected group in age, breed, and farm of origin,
were used as controls. Different isolation rooms (biosafety
level 2) were used to separate control animals from those
infected with PRRSV during the 5-month period of the exper-
iment. Animals were clinically inspected on a daily basis. Se-
rum and tonsil biopsy samples were taken at different times
postinfection (p.i.), ranging from 7 to 150 days p.i. (dpi), and
used for (i) assessment of PRRSV antibody response, (ii) in-
fectious virus isolation, and (iii) PRRSV RNA detection by
reverse transcription-PCR (RT-PCR). At 150 dpi, the experi-
ment was terminated and all of the animals were euthanatized
by electrocution, exsanguinated, and necropsied. Samples from
serum, lung, bronchial lymph nodes, and tonsils were collected
and snap-frozen for further PRRSV isolation and viral RNA
detection. Samples were assayed for infectious virus on mono-
layers of porcine alveolar macrophages (PAMs) and MARC-
145 cells (8) or by conducting bioassay experiments (see be-
low). The maintenance medium used for PAMs was RPMI
1640 (Sigma) supplemented with 10% fetal calf serum and
gentamicin (50 mg/ml). The growth medium used for the
MARC-145 cell line was Eagle’s minimal essential medium
(MEM) supplemented with 10% fetal calf serum and genta-
micin (50 mg/ml). Virus was isolated from tissue and serum
samples by inoculating six-well plates containing monolayers of
PAMs maintained at 37°C. If no cytopathic effect was observed
in the first passage in PAMs, supernatants were used as inoc-
ulum for passages in MARC-145 cells. A total of two addi-
tional passages in MARC-145 cells were done before scoring
the sample as negative for infectious PRRSV. The identity of
viral isolates was confirmed by immunofluorescence with the
monoclonal antibody SDOW-17 specific for the PRRSV nu-
cleocapsid protein (13) and identified with the identification
(ID) number of the animal from which the sample inoculum
was originated plus the date (time p.i.) when the sample was
collected. All inoculated pigs developed viremia by day 7 p.i. as
indicated by the recovery of infectious PRRSV from serum
samples in MARC-145 cells (Table 1). Seroconversion, deter-
mined by a commercial enzyme-linked immunosorbent assay
(ELISA) (Idexx Laboratories, Portland, Maine), took place
between 7 and 14 dpi, after which ELISA antibodies peaked at
28 to 56 dpi (as assessed by the commercial ELISA’s sample-
to-positive ratios). The antibody titers remained on a plateau
after peaking and then declined but remained always above the
positive threshold for the rest of the observation period (data
not shown).
The frequency of recovery of infectious virus by cell culture
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assays (PAMs or MARC-145 cells) decreased with time, and
PRRSV was recovered only occasionally up to 84 dpi (Table
1). In addition to cell cultures, experimental inoculation of
susceptible swine (bioassay experiment) was performed with
samples taken at 84 and 150 dpi. We inoculated 1- to 2-week-
old piglets, obtained from an unvaccinated PRRSV-free herd,
to assay for the presence of infectious PRRSV in tissue col-
lected from the pigs at long-term-p.i. periods. Tonsil biopsy
samples collected at 84 dpi from each infected animal were
ground separately and mixed with a serum sample collected at
the same time p.i. from the same animal. Each homogenate
typically consisted of 50 to 80 mg of ground tonsil tissue and 2
ml of serum. Approximately 0.5 ml from each homogenate was
stored at 280°C for viral isolation assay in cell cultures. The
remaining 1.5 ml of homogenate was diluted to a volume of 8
ml with MEM, supplemented with gentamicin (50 mg/ml), and
used to inoculate the piglets. Tissue samples taken at necropsy
(150 dpi) from the infected animals were ground separately.
Pools of ground tissue from each individual pig were mixed
with serum collected at the same p.i. time point from the same
animal. Typically, each homogenate consisted of 5 to 10 g each
of ground lung, lung lymph node, and tonsil tissues and 4 ml of
serum. MEM supplemented with gentamicin (100 mg/ml) was
added in a volume of 15 ml. The suspension was then frozen
and thawed and clarified by low-speed centrifugation. Super-
natants were then transferred to new sterile tubes and diluted
1:5 in MEM containing 100 mg of gentamicin per ml. A volume
of 12 ml from each sample suspension was used to inoculate
the piglets. Bioassay experimental piglets were inoculated with
1 ml of the supernatants from tissue suspension delivered in
each nostril with the remaining 10 ml of inoculum being de-
livered intraperitoneally. Each inoculated animal remained in-
dividually isolated during the bioassay experiments for a period
of 3 weeks. The progress of the experimental inoculation was
monitored by daily clinical observation and weekly serum sam-
pling which was used for the assessment of viremia and
PRRSV antibody response by ELISA. The isolates obtained
through this bioassay were identified with the ID number of
the animal from which the sample inoculum originated and the
corresponding date of collection, followed by the letter “b.” At
84 dpi, we used 10 piglets for the bioassay experiment (one for
each principal animal). For the sake of economy, at 150 dpi we
assessed only the samples from those animals that had yielded
positive results at 84 dpi.
PRRSV was isolated in cell cultures from a tonsil biopsy
sample of pig 32 at 56 dpi and from a homogenate of tonsil and
serum samples from pig 3 at 84 dpi. Interestingly, 5 out of 10
animals were persistently infected at 84 dpi, and from those,
two animals remained persistently infected up to 150 dpi, as
indicated by the development of viremia and seroconversion in
the bioassay piglets (Table 1). We did not quantitate the in-
fectious virus per gram of sample. However, the difficulty in
isolating infectious PRRSV by conventional methods and the
strict requirement of bioassay inoculation in order to demon-
strate PRRSV infectivity in later stages of the observation
period (approximately 3 to 5 months p.i.) would suggest that
the amount of infectious virus was decreasing progressively
throughout the experiment.
To study the occurrence of viral gene expression, a strand-
specific RT was performed to reverse transcribe the negative
form of the viral RNA that occurs during replication, using the
primer 59-GACTGCTTTACGGTCTCTC-39 (11), which an-
neals to the replicative (minus) RNA form at the 39 end of the
leader. PCR and seminested PCR, with 35 cycles of amplifi-
cation each, were carried out on the strand-specific RT prod-
ucts. For the PCR, the following oligonucleotides were used:
59-TGCCGCACGGTTTCATCCGATTG-39 (forward primer,
nucleotide [nt] 14728 to 14750), outer reverse primer 59-GGT
GATGCTGTGACGCGGATCAG-39 (nt 15228 to 15250), and
inner reverse primer 59-GCAAGTCCCAGCGCCTTGATT-39
(nt 15138 to 15158). The end product of the seminested PCR
was 430 nt long corresponding to the last 170 nt from ORF6
and the first 270 nt of ORF7. A PCR for the constitutive
b-actin gene of swine was performed on the tissue samples
collected at necropsy as control for the RNA extraction and
RT reactions using previously published primers (16). All RT
reactions were performed using SuperScript II reverse tran-
scriptase (Gibco BRL) following the manufacturer’s instruc-
tions. The PRRSV-negative RNA form was detected at 28 dpi
in tonsil samples from 8 out of 10 infected animals (Table 2),
thus suggesting the occurrence of active viral gene expression
in the tissues under study. There was a significant decrease in
the number of positive animals by day 119 p.i. compared to the
more acute-phase samples at 28 dpi. Only pig 31 showed evi-
TABLE 1. PRRSV isolation in cell culture or in bioassay
experiments from pigs experimentally infected
with the 16244B isolatea
Animal
ID no.
Result for assay at dpi:
7 (cc) 56 (cc)
84 150
cc ba cc ba
3 1 2 1 1 2 1
4 1 2 2 2 2 ND
9 1 2 2 2 2 ND
14 1 2 2 2 2 ND
17 1 2 2 2 2 ND
22 1 2 2 1 2 2
23 1 2 2 2 2 ND
27 1 2 2 1 2 2
31 1 2 2 1 2 1
32 1 1 2 1 2 2
a Viruses were isolated in cell culture (cc) (PAMs or MARC-145 cells) or in
bioassays (ba). Day 7 samples were serum samples and were assayed only on
MARC-145 cells. Day 56 and day 84 samples were tonsil biopsy and serum
samples. Day 150 was the time of necropsy (tonsil, bronchial lymph node, lung,
and serum samples). 1, positive; 2, negative; ND, not done.
TABLE 2. PRRSV-negative strand-specific RT-PCR amplification
in tissue samples of pigs experimentally infected
with PRRSV isolate 16244Ba
Animal
ID no.
Result for dpi:
28 119 150
3 2 2 2
4 1 2 2
9 1 2 2
14 1 2 2
17 2 2 2
22 1 2 2
23 1 2 2
27 1 2 2
31 1 1 2
32 1 2 2
43 2 2 2
47 2 2 2
50 2 2 2
a Animals 43, 47, and 50 are uninfected controls. RT-PCR was performed on
RNA from tonsil samples (days 28 and 119) and from tonsil, lung, lymph node,
and serum samples (day 150). 1, positive; 2, negative.
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dence of persistent PRRSV gene expression by minus-strand-
specific RT-PCR in the tonsil tissue (Table 2). We were unable
to detect the negative form of PRRSV RNA at 150 dpi (Table
2). However, using random hexamers in the RT reaction,
PRRSV total RNA was still detected in tonsil tissue from one
of the persistently infected pigs (animal 31 [data not shown])
for which virological evidence of persistent PRRSV was pro-
vided in the bioassay experiment also (Table 1). The low level
of detection of PRRSV RNA (minus) during the late-p.i. pe-
riod could be a reflection of the lower frequency of this tem-
plate in the replicative process, which made it undetectable in
most of the animals by the technique we used.
Evidence for persistence of PRRSV infection in individual
animals has been reported previously (5, 17, 19). In this report,
we provide evidence that the virus persists in a replicating,
infectious state in a continuously decreasing percentage of the
convalescent animals. Together, the data from viral isolation
and negative RNA RT-PCR indicate that PRRSV persists
through a “smoldering” type of infection in which the virus
replicates at low levels over time.
To measure the genetic stability of the PRRSV during per-
sistence, we analyzed sequences from viruses recovered at 7
dpi (samples 3-7, 22-7, 27-7, 31-7, and 32-7), at 84 dpi (samples
3-84, 3-84b, 22-84b, 27-84b, 31-84b, and 32-84b), and at 150 dpi
(samples 3-150b and 31-150b). Random hexamers were used to
reverse-transcribe total RNA extracted from monolayers of
MARC-145 cells infected with the above-mentioned PRRSV
isolates recovered during the experiment. The resulting cDNA
was used as a template in the PCR to amplify segments of the
PRRSV genome from nt 25 at the 59 NCR to nt 675 in ORF1a,
the complete sequence of ORF2 to ORF7, and the 39 NCR (all
of them based on our published sequence of PRRSV 16244B
[GenBank accession no. AF046869]). RT-PCR products and
cloned cDNA inserts were sequenced by the dideoxynucleotide
chain-termination method (15). Sequencing reactions were
prepared with the BigDye Terminator Cycle Sequencing kit
(Perkin-Elmer). Sequences were determined with an ABI
PRISM 377 automated DNA sequencer and an ABI PRISM
3700 DNA analyzer. The ABI sequence software version 3.3
was used for lane tracking and trace extraction. Further cDNA
sequencing, genome assembling, and computer analysis were
done as previously described (2). A total of 4.2 kb was se-
quenced and analyzed for each virus isolate. The PRRSV 59
NCR and the 39 NCR were extremely stable during long-term
persistence, suggesting that virus persistence is not a conse-
quence of mutations in regions most likely involved in poly-
merase recognition or transcription initiation. The frequency
of nucleotide substitutions at 7 dpi varied from 0 to 0.6/1,000
nt. By day 84 p.i., the frequency of nucleotide substitutions
rose, ranging from 2.1 to 5/1,000 nt (data not shown), which is
similar to that observed for the S gene of the coronavirus
mouse hepatitis virus (1). At day 150 of persistence, the fre-
quency of nucleotide substitutions varied between 3.8 and 3.6
in the two samples analyzed (3-150b and 31-150b) (data not
shown), which is still similar to that reported elsewhere for the
persistence models of the coronavirus mouse hepatitis virus
(1). An observed feature of the nucleotide substitutions during
persistence was that the mutations were almost entirely tran-
sitions. The observed bias in PRRSV persistence was higher
than that reported for other virus models (1, 18) and may very
well be a consequence of the PRRSV replication in a naive
piglet during the bioassay experiment.
The results of the predicted protein sequence analyses are
summarized in Table 3 as translated amino acid sequences
compared to the parental PRRSV 16244B strain. No changes
were observed in isolates recovered at 7 dpi. However, at 84
and 150 dpi, changes were observed in all the samples ana-
lyzed. The average nonsynonymous/synonymous mutation ra-
tios for individual genes at 84 and 150 dpi indicate that selec-
tive pressure for amino acid change is likely exerted in genes
coding for the major viral glycoproteins during establishment
of persistence (Table 4). In fact, ORF3, ORF4, and ORF5
were the more variable genes during persistence, while ORF2
changed only moderately (Tables 3 and 4). Nsp1a and ORF6
were substantially less variable than the glycoproteins, and the
ORF7 predicted protein remained unchanged during persis-
tence (Table 4). Similar observations were reported for ORF2
to ORF7 of other arteriviruses (7). The high degree of con-
servation observed for N protein from persistent PRRSV iso-
lates agrees with data reported for other arteriviruses (7). This
protein as well as the 59 NCR and 39 NCR have a potential role
in genome packaging during virion assembly or in the complex
TABLE 3. Predicted amino acid substitutions in Nsp1a and ORF2 to ORF7 from persistent PRRSV isolates
recovered from pigs infected with PRRSV strain 16244B
Genome
region
Amino acid substitution from PRRSV isolate:
3-7 3-84 3-84b 3-150b 22-7 22-84b 27-7 27-84b 31-7 31-84b 31-150b 32-7 32-84b
Nsp1a A114T A114T I81V A114T
ORF2 Q189R Q189R Q189R Q189R
A223T A223T L203P A223T
ORF3 I215T I215T I215T S15N S15N H79Y I215T S15N
T64A S106G
Q151R
ORF4 E35K E35K E35K A45V A45V S51G E35K A45V
M157T F118L V127E
ORF5 N58D N58D N58D D61N D61N D61N N58D D61N
Y141H Y141H Y141H
ORF6 K70E K70E T63M K70E
ORF7
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transcription process (6); thus, structural restrictions are im-
posed on nucleotides in this region of PRRSV, as indicated by
our results.
Although antigenic variation of gp3 has been associated with
variation of PRRSV through serial passage in swine (9), the
mechanism of variant selection during persistence is not clear.
High glycosylation and variability of PRRSV gp3 suggest that
this protein is involved in virus-host cell interactions (9, 12).
Our data indicate that strong selective pressure is likely ex-
erted on the PRRSV gp3 during establishment of and through-
out persistence in the natural host. Regarding gp5, two out of
three changes observed were located in the ectodomain region
of the protein. Changes in the PRRSV gp5 ectodomain have
been associated with selection of a viral subpopulation through
quasispecies evolution during persistence (14). Although we
identified mutations in the ectodomain of the glycoprotein, we
did not observe the mutation at position 34 that appeared to be
the hallmark of the quasispecies identified by Rowland et al.
(14) during persistence. Ours and theirs are not necessarily
contrasting results, because Rowland et al. also reported that,
when they repeated the experiments using a different strain of
PRRSV, they again observed the emergence of a new sub-
population of PRRSV RNA, characterized by a mutation in a
different position of the ectodomain (14).
Recently, PRRSV M protein has been reported to be a
major target of cell-mediated immunity (3). The M protein is
a structural protein with three transmembrane domains, and
structural requirements likely restrict amino acid alteration in
the protein. Surprisingly, we identified two amino acid muta-
tions in this protein (Table 3). Although we did not study the
cell-mediated response of the animals in these experiments
and very little is known in general about the topic, our results
could suggest that mutations in M protein determine a delay in
the process of viral clearance from the body.
The results of this study suggest that PRRSV persists
through a “smoldering” type of infection in which the virus
replicates at low levels over time. The virus eventually clears
the body and seems to do it in the majority of the animals by
150 dpi or shortly thereafter. High genetic stability was ob-
served in both NCRs and in the nucleocapsid protein during
persistence. However, genes coding for the glycoproteins and
the M protein of PRRSV had mutations that could be associ-
ated with putative changes which may be involved in mainte-
nance of persistence.
Nucleotide sequence accession number. The PRRSV se-
quences reported in this paper have been deposited in Gen-
Bank under accession no. AF299404 through AF299417.
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